Showing posts with label Parkinson's disease. Show all posts
Showing posts with label Parkinson's disease. Show all posts

Wednesday, June 11, 2014

Yet another story about treating Parkinson's with stem cells




A neurosurgery team will next month transplant cells from aborted human fetuses into the brain of a person with Parkinson's disease. The operation breaks a decade-long international moratorium on the controversial therapy that was imposed after many patients failed to benefit and no one could work out why.
People with Parkinson's disease suffer from a degeneration of neurons that produce the neuro­transmitter dopamine, which is crucial for normal movement. This often leaves patients with severe mobility problems. Standard treatment includes the drug l-dopa, which replaces dopamine in the brain but can cause side effects. The cellular therapies aim to replace the missing neurons with dopamine-producing (dopaminergic) cells from fetal brains or with those derived from human stem cells. But the trial comes just as other sources of replacement cells derived from human stem cells are rapidly approaching the clinic. And this time, scientists want to make sure that things go better. So the teams involved in all the planned trials have formed a working group to standardize their research and clinical protocols in the hope that their results will be more easily interpretable.
The moratorium on replacement-therapy trials was introduced in 2003 because the early fetal-cell studies had produced varying results that were impossible to interpret.
Read the rest of the article here:


Saturday, December 14, 2013

Parkinson’s stem cell project aims for 2014 approval




Parkinson's patient Ed Fitzpatrick speaks about stem cell research for his disease. Fitzpatrick talked on a Dec. 7 panel at the World Stem Cell Summit in San Diego.
Parkinson's patient Ed Fitzpatrick speaks
about stem cell research for his disease.
Fitzpatrick talked on a Dec. 7 panel
at the World Stem Cell Summit in
San Diego.


By Bradley J. Fikes 
2:01 P.M.DEC. 8, 2013

 For eight local Parkinson's patients seeking treatment with stem cell technology, 2014 could bring the milestone they've been anticipating.

If all goes well, the U.S. Food and Drug Administration will approve an attempt to replace the brain cells destroyed in Parkinson's. The new cells, grown from each patient's own skin cells, are expected to restore normal movement in the patients.

Because the new brain cells are made from the patients' own cells, immunosuppressive drugs shouldn't be needed. Ideally, patients could stop taking their medications and resume normal activities for many years, or even the rest of their lives.

The project, Summit4StemCell.org, is a collaboration between three nonprofits. The Scripps Research Institute handles the science; Scripps Clinic takes care of the medical side; and the Parkinson's Association of San Diego helps to raise money for the self-funded project.

The rest of the story...with lots of videos of the researchers explaining the process and progress. 

Thursday, October 10, 2013

My Post to the Katie Couric show

At the end of the Catie Couric show yesterday afternoon (Oct 9, 2013), she invited anyone interested to 'keep the conversation going' by going to her site and telling our stories, etc. Here's what I sent in. So far I can't find it listed among the more than 1200 comments that are rolling in. Perhaps it was too long, so I'll post it here for anyone who's interested in reading it...

Dear Katie,

Thank you so much for covering this difficult topic on your show, and being so genteel yet also bringing both sides of the controversy together so adeptly.  You and your staff chose your guests well.

I want to share with you my story, and a few opinions after dealing with Lyme issues for a decade.

I grew up in eastern Pennsylvania, and often worked and played in the woods. Woods and deer surrounded our house. I worked as a surveyor's apprentice and for a tree surgeon as summer jobs. Thus, it was not uncommon to have ticks on me after a day's work. 

I am now 60 and live in California, where I have been since 1977. At ages 18, 30, and 50 I had major meltdowns. My symptoms were feelings of pressure in the neck and head, insomnia, depression, and anxiety, mostly. Age 50 was the worst. The other two events lasted 1-2 year, and eventually self-corrected.

But at age 50, I did not recover, and I was incredibly ill. My mind went haywire to the point where I had to go to psychotherapy every day for a month, at the outset, just to prevent me from committing suicide.

Thursday, September 26, 2013

Patient's own cells might be used as treatment for Parkinson's disease

This illustration shows the image of autotransplantation. The paper shows evidence only for neural cells and the brain, not for other organs. Immunogenicity in other organs needs to be explored.
(Photo Credit: Stem Cell Reports, Morizane et al)
Induced pluripotent stem cells (iPSCs) taken from a patient hold great therapeutic potential for many diseases. However, studies in rodents have suggested that the body may mount an immune response and destroy cells derived from iPSCs. New research in monkeys refutes these findings, suggesting that in primates like us, such cells will not be rejected by the immune system. In the paper, publishing September 26 in the ISSCR's journal Stem Cell Reports, published by Cell Press, iPSCs from nonhuman primates successfully developed into the neurons depleted by Parkinson's disease while eliciting only a minimal immune response. The cells therefore could hold promise for successful transplantation in humans.

iPSCs are cells that have been genetically reprogrammed to an embryonic stem-cell-like state, meaning that they can differentiate into virtually any of the body's different cell types. iPSCs directed to differentiate into specific cell types offer the possibility of a renewable source of replacement cells and tissues to treat ailments, including Parkinson's disease, spinal cord injury, heart disease, diabetes, and arthritis.

Studies in rodents have suggested that iPSC-derived cells used for transplantation may be rejected by the body's immune system. To test this in an animal that is more closely related to humans, investigators in Japan directed iPSCs taken from a monkey to develop into certain neurons that are depleted in Parkinson's disease patients. When they were injected into the same monkey's brain (called an autologous transplantation), the neurons elicited only a minimal immune response. In contrast, injections of the cells into immunologically unmatched recipients (called an allogeneic transplantation) caused the body to mount a stronger immune response.

See the rest of the story:
 http://www.sciencecodex.com/patients_own_cells_might_be_used_as_treatment_for_parkinsons_disease-120075

Monday, September 16, 2013

Is a Tick Bite Causing Your Depression?

The symptoms your doc could be missing

From Prevention magazine
By Leah Zerbe


However you feel about the mild winter we just experienced (Yay for less shoveling! Boo for global warming!), one thing no one’s excited about: The explosion in the tick population it caused. And while most people know that ticks can carry Lyme disease, many of us know very little about the hard-to-pin-down disease. Here’s how to recognize the symptoms and protect yourself from Lyme disease.

What is Lyme disease? There’s a reason experts call it “The Great Imitator.” Lyme disease results from inflammation caused by Lyme bacteria, and the symptoms can mimic everything from rheumatoid arthritis and lupus to anxiety disorders and depression. Most often the result of a tick bite, Lyme disease's range of devastation is daunting: The same Lyme germ causing joint pain in one person could lead to symptoms associated with multiple sclerosis and Lou Gehrig's disease in another.

Read more:

http://www.prevention.com/mind-body/emotional-health/what-you-need-know-about-lyme-disease

Friday, August 10, 2012

Parkinsons Disease Treatment Options

An excellent and rich page listing resources for those with Parkinson's. Books, diet, exercise, and more. I have just discovered it, after being approached by the site's author to be interviewed.

http://www.blog.parkinsonsrecovery.com/parkinsons-disease-treatment-options

Sunday, August 5, 2012

Portrait of Bob and his meds

I was digging through my supplies the other day and realized that I wanted to visually document the preposterous amount of supplements, prescription drugs, Chinese medicine, homeopathics, needles, syringes, saline bags, and so on that I have in my Lyme-fighting arsenal. Even I was amazed (and depressed about) how many jars, bottles, vials, tubes, bags, and so forth I have purchased over the years, not to mention that my poor liver and kidneys and other body parts have had to assimilate, break down, and excrete these drugs. All this stuff has cost hundreds of dollars, if not thousands. 

I also thought it would be good for my doctors (and any doctors reading this) to get a sense of what a typical chronic-Lyme disease patient has to deal with over time. 

I decided to organize them outdoors, on top of my defunct hot tub. (A friend Photoshop'ed in the sky, replacing the dead plants and drab redwood wall). Looks kind of goofy, but I did the setup of all the bottles and whatnot there simply because there was good light for a photo, and I don't have another flat surface to put everything on.
It's a full-time job just remembering what to take, and when!
In the lower photo you can see the general layout. The glass vials in the middle are empty Ceftriaxone (AKA Rocephin, an antibiotic) IV bottles, along with tiny ones that were filled with glutathione and phosphatidyl choline, which I take IV to help the liver do its detox job better.  
Rx drugs are on the right, Chinese herbs are just behind the Rocephin bottles and in the little plastic (front, left). Homeopathics are in the dropper bottles behind the Chinese herbs. Just about everything else are supplements (aminos, vitamins, and various herbs, heavy-metal binders, etc). My IV pole with some Rocephin in the bag/line is standing next to me. 

On the back, right are glass vials of seawater from some supposedly-magical source off the coast of France. A homeopath/naturopath sold me those. It's called Quinton water. Supposedly good JuJu in that water, but I didn't notice anything. You have to break off the tip of a glass vial in order to get the Quinton water out. A tad scarey the first couple of times. I was afraid I'd cut myself, not to mention my fear of drinking little glass shards. In the back, middle, are heparin and saline flushes (pre-loaded single-use syringes). You go through a lot of those if you have a PICC or a Port. 

I had forgotten about some of these chapters of my treatment. I'd rather not remember, actually. There have been so many!


A bit more of a close-up to make things more visible.

Sunday, June 17, 2012

FRONTLINE: my father, my brother, and me: watch the full program



Entire Frontline piece (56 mintues) about living with Parkinson's disease. Produced by Dave Iverson. 

In 2004, FRONTLINE correspondent Dave Iverson received the same news that had been delivered to his father and older brother years earlier: He had Parkinson's disease, a degenerative neurological disorder that affects more than 1 million Americans, the causes of which remain largely unknown and the cure for which has proved frustratingly elusive.

http://www.pbs.org/wgbh/pages/frontline/parkinsons/view/?autoplay


Tuesday, June 12, 2012

Researchers identify predictive biomarker for Parkinsons disease

Because there is currently no laboratory test that can diagnose Parkinson's disease, it is practically impossible to detect those individuals who are in the earliest stages of the disease. As a result, Parkinson's disease can only be diagnosed by a clinical neurological examination based on findings suggestive of the disease.

But researchers from the Technion-Israel Institute of Technology Faculty of Medicine have now identified a biomarker comprised of five genes shown to predict Parkinson's disease with high accuracy. The findings are reported in a research article now published online by the scientific journal Molecular Neurodegeneration....

Read full article:
http://www.news-medical.net/news/20120605/Researchers-identify-predictive-biomarker-for-Parkinsons-disease.aspx



People with early PD show increased arm swing

People with Parkinson's disease swing their arms asymmetrically -- one arm swings less than the other -- when walking. This unusual movement is easily detected early when drugs and other interventions may help slow the disease, according to Penn State researchers who used inexpensive accelerometers on the arms of Parkinson's disease patients to measure arm swing....

Read article
http://www.news-medical.net/news/20111214/People-with-Parkinsons-exhibit-increased-arm-swing-during-early-stages.aspx

Wednesday, May 30, 2012

Serratiopeptidase: The Answer for Chronic Pain?



If you suffer from pain to any extent – occasionally, chronically or somewhere in between – an enzyme known as serratiopeptidase may just be the answer for you. This is especially true if you have an aversion to, or are experiencing any side effects of, the medication you currently use for pain management. Whether you take prescription or over-the-counter “painkillers,” serratiopeptidase is a safe, natural alternative with no known side effects.

Serratiopeptidase, also known as serrapeptase, is a proteolytic (that is, having the ability to break down proteins into simpler compounds) enzyme which is naturally present in the silkworm intestine. Now, before you go running for cover, screaming, “I’m not swallowing anything that came from a worm’s innards!” – let me just emphasize: The type that is available to consumers today is processed through fermentation of plant-grown enzymes, and is generally of such purity that it is suitable even for consumption by vegetarians. ...

Read more:
http://serratiopeptidase.weebly.com/


Tuesday, May 29, 2012

Announcing 23andMe's First Patent in Parkinson's


23andMe 

Parkinson's Research Initiative


Dear Robert,

In October, we announced our discovery that a version of the gene called SGK1 may be protective against Parkinson's in those carrying the high-risk version of the LRRK2 gene. We were immediately excited about this discovery because such a finding could be the basis of a new drug target for Parkinson's. So we partnered with researchers at Scripps to explore this finding in greater detail. If this research is successful, we hope that a biotechnology or pharmaceutical company will develop this into a new therapy so that patients can benefit from the finding. Because bringing a new treatment to market generally takes more than ten years and costs more than $1 billion, pharmaceutical companies typically only invest in developing treatments that are protected by patentable findings. Therefore we filed for a patent on these findings.

We are excited to announce that this patent has been approved. This is exciting as it gives us the best shot of translating this finding into a new treatment that could help people with Parkinson's.

We will continue to update you as we learn more about how SGK1 works and if it could be translated into a new treatment for Parkinson's.

You can read more about what this patent means in our recent blog post.   

Warmest wishes,  
Emily Drabant, Ph.D.  
Parkinson's Research Manager

PS - We are still enrolling! If you know someone with Parkinson's, they are eligible for free 23andMe genotyping and research participation at www.23andme.com/pd

There are many ways to advance Parkinson's research. Find out which clinical trials need you at the Fox Trial Finder.   





Tuesday, May 22, 2012

Lyme Conference video from Skidmore College now available online

The live webcast of the Lyme conference hosted by Skidmore College in New York last week was quite emotional at times, and certainly informative. Missed it? No worries. The video stream was recorded for those who want to watch it after the fact.

They broke it into three parts. (Loved the typo in the file names - 'bourne' instead of 'borne'. Someone's got the Bourne Supremacy on their mind. Then again, taking on the CDC, IDSA, and NY State is kind of in the action-movie category.)

IMHO, Drs Richard Horowitz and Kenneth Leigner were the big attractions. Horowitz gave a high-energy Power Point mini-course in Lyme and associated diseases. Leigner fully socked it to the establishment IDSA contingent, with a dressing down the likes of which I hadn't heard from an LLMD before. Pam Weintraub was the keynote speaker - passionate and articulate as always.

For direct links to the videos, you can click here:

Part 1:
http://livestre.am/3TIV9

Part 2:
http://livestre.am/3U6GK
At 1:47 (one hour, 47 minutes) into part 2, Dr. Leigner makes his compelling statement.

Part 3:
http://livestre.am/3U8oL

Here's the program and list of speakers:

Schedule

9:00 Morning Session Opens Christina T. Fisk, Co-Chair Organizing Committee
Welcome to LymeNEXT Congressman Chris Gibson, 20th Congressional District, NY

9:15 Keynote Address
Into the Woods: The Patient Journey through Lyme Disease
Pamela Weintraub, Executive Editor, Discover Magazine and author of Cure Unknown: Inside the Lyme Epidemic

10:00 The Scope and Economic Burden of Lyme Disease
An Epidemic of Lyme Disease? Holly Ahern
The Economic Impact and Burden of Lyme Disease Lorraine Johnson

11:15 A Diagnosis that Fits the Disease - Multiple Chronic Infectious Disease Syndrome (MCIDS) Richard I. Horowitz, MD

1:20 Afternoon Session Opens Christina T. Fisk, Co-Chair Organizing Committee

1:30 Protecting Physicians who Treat Lyme Disease Daniel Cameron, MD

2:00 Preventing Transfusion-Transmitted Babesiosis David Leiby, PhD

2:45 New Methods for Lyme and TBD Detection Ahmed Kilani, PhD

3:15 A “Manhattan Project” for Lyme Disease Kenneth Liegner, MD

3:45 Closing Remarks Congressman Chris Gibson




The Low Dose Naltrexone

"Low Dose Naltrexone (LDN) may well be the most important therapeutic breakthrough in over fifty years. It provides a new, safe and inexpensive method of medical treatment by mobilizing the natural defenses of one's own immune system.

LDN substantially reduces health care costs and improves treatment of a wide array of diseases. Unfortunately, because naltrexone has been without patent protection for many years, no pharmaceutical company will bear the expense of the large clinical trials necessary for FDA approval of LDN's new special uses. It is now up to public institutions to seize the opportunity that LDN offers."

Read entire article:


Saturday, May 19, 2012

US baby boomers urged to take hepatitis C blood test

From the BBC News -- May 17, 2012

The CDC is recommending a one-time blood test to check for the virus
Hep C vaccine trial 'promising'

US baby boomers have been advised by health officials for the first time to get tested for the liver-destroying virus hepatitis C.

Those born between 1945-1965 are most likely to be infected but it is thought only a quarter of this generation has been tested for the virus.
The US Centers for Disease Control (CDC) believes its campaign could save more than 120,000 lives.

The CDC estimates some 17,000 hepatitis C infections currently occur each year.

Health officials believe hundreds of thousands of infections occurred each year in the 1970s and '80s, when baby boomers would have been young adults.

The disease, which was first identified in 1989, can take decades to cause liver damage. Many of those infected may not even be aware of their condition.

One reason for the CDC advice is that from 1999-2007 the number of Americans dying from hepatitis C-related diseases nearly doubled.
Two million of the 3.2 million Americans known to be infected with the blood-borne virus are baby boomers.

CDC officials believe new testing could lead to 800,000 more baby boomers seeking treatment.

Many infections of hepatitis C come from sharing needles to inject drugs. Before widespread screening began in 1992, it was also transmitted through blood transfusions.

"The CDC views hepatitis C as an unrecognised health crisis for the country, and we believe the time is now for a bold response," said Dr John Ward, the CDC's hepatitis chief.

Continue reading the main story
http://www.bbc.co.uk/news/world-us-canada-18127654

Thursday, May 10, 2012

Pathogens Causing PD?

Found at:
http://neurotalk.psychcentral.com/thread33514.html
It is by no means certain that pathogens have nothing to do with PD
Just a couple of possibilities-
1) A pathogen called Nocardia has been shown to cause parkinsonism.
2) You may have heard of the German researcher Braak's work demonstrating that *something* enters the nerve fibers in the nose and stomach and then leaves a trail of Lewy bodies like bread crumbs as it marches into the brain en route to the substantia nigra. One other thing that follows a similar pattern is the polio virus.

Tuesday, May 1, 2012

Thoughts about Depression

Depression and intense anxiety have been my primary symptoms when I have had acute Lyme flareups. The depressions have been sudden, quite scary, and sometimes long-lasting. It is as though my brain and emotions fall into a deep, dark well. The closest description I have found was wriiten by William Styron in his little book called Darkness Visible. Here it is:

http://www.amazon.com/Darkness-Visible-A-Memoir-Madness/dp/0679736395

After reading this and sharing with family members, I felt less alone. I knew that at least a famous writer really understood. I was a struggling author and so his story was one I could relate to. Then I started serious psychotherapy, and even earned a masters degree in psychotherapy, at age 55, to better understand myself and to help others.

When I saw my psychotherapy clients who were experiencing clinical depression I really understood that depression is a truly dark hell-realm. When I was in this depressed place, it was nearly impossible to remember that it was the result of how my brain was working, that it can be temporary, and that there is fun, lightness, and happiness waiting for me at the end of the tunnel. As anyone who has been clinically depressed (not just sad or grieving due to a loss -- these are natural and approrpriate responses to life and loss) knows, it can feel like you are in a nightmare that you just can't wake up from. A dark veil has fallen in front of your eyes, and the whole world looks and feels bleak.

I can now sense when my depressions are physical (organic) vs situational (or both). Two or three days ago, I felt it coming up again. I find mindfulness practice to be very helpful nowadays when depression starts creeping in. I don't panic, I just notice it ("Oh, hi depression, it's you again..."). I remind myself that it is probably temporary, and I try to do something nice for myself. A hot bath, see a friend, take a sauna. I also hit the Omega-3's, and get some exercise and sun. Usually it lifts. I also observe my thinking patterns. Have I been thinking about some mistake or 'failure' I have committed? Am I beating myself up about something? If so, I try to correct the thinking.

Of course, the way a chronic illness affects our lives IS pretty depressing. Losing my health, my job, my money, sex drive, ability to be in a relationship effectively, and my sense of well-being is depressing! It certaiinly isn't a cake walk. So it's actually pretty reasonable for many of us with chronic Lyme, Parkinson's, or other chronic diseases to be prone to depression.

My psychopharmacology professor used to say the best treatment for depression was dancing naked in the sunshine with your lover. That gets you touch, exercise, and Vitamin D. All three will increase seratonin. In lieu of a lover, getting a massage will meet our need for touch (well, sort of).

Last week, as my old friend depression was lurking about, hiding behind imaginary trees and standing in dark corners, I decided to really give him a run for his money. I packed up my car with my musical instruments and accepted an invitation to play a gig with a rock band. It's a group I play in a few times a year. I joined them in Yosemite National Park where they were playing at an annual bash called The Spring Fling, in El Portal. This is a small town just outside of Yosemite.

I had been on the fence about going. Would it tired me out? What about my medical regimen? What if I got sicker? Where would I sleep? Could I even play a keyboard on stage in front of an audience, when with just the smallest bit of anxiety I start to shake like a leaf??

In the end, I had a ball with my musical buddies. I stayed for five days and really enjoyed myself. Music, sunshine, amazing natural beauty, tons of young, vibrant people who work in the Park. Of course, at 59, I feel like a relic in their company, and also I want to tell them all to protect themselves from Lyme-carrying ticks, but I decided not to be the harbinger of bad news, and just to drop it and enjoy myself. Getting out in that beautiful nature, and having a nice drive for five hours each way was just what the doctor ordered!

It was not easy to do (especially because my Parkinsonism makes me shake really badly under pressure, and at times I was barely able to play my keyboard), but I took my PD meds regularly and got through it. A couple of times during the gig I had to stand up from my chair and keyboard and just dance around to shake off the nervousness and tremors. Luckily that looks pretty normal in a rock-band dance hall! (It doesn't go over as well at a classical piano recital.)

I guess what I'm saying is just an echo of what our hero Dr. Joe Burrascano says: People who get better are the ones who don't identify themselves with their disease. They continue to live their lives. They don't structure their lives around their illness. They still enjoy their people and their hobbies. They smell the roses and they cuddle with their pets. (My paraphrase.)

-Bob

Tuesday, April 10, 2012

Berries may reduce Parkinson’s disease risk in men: Study

A new study has found that men who regularly consume foods rich in flavonoids, such as berries, apples, certain vegetables, tea and red wine, may significantly reduce their risk for developing Parkinson's disease. The study was published in the journal Neurology this week. It added that there was no such effect among women.

Tuesday, April 3, 2012

Lilou's interview - Luc Montagnier - infections leading to autism and PD

Professor Luc Montagnier - infections leading to autism and pd


This video interview with Nobel Prize winner Luc Montagnier claims a connection is implied between Lyme Disease and PD (Parkinson's disease).

Wednesday, March 21, 2012

Dykenesia Trial Yields Promising Results for Patients

A note from the Michael J. Fox Foundation:

Today, good news in the search for a treatment for dyskinesia, the uncontrollable movements that are so often a disabling side effect of Parkinson's disease medication.
Swiss biotech and Michael J. Fox Foundation awardee Addex Therapeutics has announced positive results from a phase 2 clinical study of their drug candidate dipraglurant, which is being tested as a therapy to be taken in conjunction with levodopa (the gold standard for treating PD). By targeting the brain's glutamate system, the hope is that the dipraglurant would allow patients taking levodopa to experience better "on" times without dyskinesia.

Dyskinesia is of course, a real roadblock to the long term treatment of PD. Finding a successful treatment to limit this side effect could have major implications for those living with PD today. While such a therapy is still a ways off, the Addex results represent an important next step in driving a potential drug for dyskinesia to market.

To learn more, read the Foundation's News in Context interview with Bill Langston, MD, scientific director and chief executive officer of The Parkinson's Institute in Sunnyvale, California, and staff scientists Audrey Dufour, PhD and Jamie Eberling, PhD.